Management Team
Degree in Medicine and Specialization in onco-hematology at University of Pisa, Italy. He covered the position of Vice President Business & Commercial Operations Europe in the start-up phase of Cell Therapeutics, with the responsibility of Sales & Marketing (Trisenox), Medical Affairs & Business Development (Xyotax, Pixantrone) for all European Countries. Giuseppe spent 11 years in Roche as Head of Hematology-Oncology and Transplant Area and he was responsible for the launch of Granulokine (G-CSF filgrastim) and NeoRecormon (erithropoietin). As member of the Global Product Team (Roche-Genentech-Idec), he also had the opportunity to manage early business and scientific evaluation, phase I/II clinical development and launch of the first monoclonal antibody in non Hodgkin Lymphomas (Rituximab). He also covered the position of Medical Director at Pharmion and Marketing Director at Bristol-Myers Squibb-oncology.
Degree in Pharmacy University of Siena Italy. Legal Representative of 1A Pharma (Generics). V.P. Regulatory and Government Affairs Worldwide at UBP (anticancer, antiviral and CNS) and Sr. Director European Regulatory Affairs/Government Affairs at Vicuron Pharmaceuticals (antibacterial, antifungal – Rapporteur/Co-rapporteur). Pier Francesco has also covered the role of Director Regulatory and Government Affairs European Union/East and Central Europe at Wyeth C.H. (OTC, Medical Device, Cosmetics, Dietetics, Food Supplements, Nutrition, Herbals – European Dept. start-up) and Plant Director at Wyeth C.H. Italy; Regulatory and Government Affairs, Compliance Director at Smithkline Beecham (1st Hepatitis A vaccine registration). Regulatory, Licensing and “Entwicklung Koordinationen” at Boheringer Ingelheim.
Degree in Medical Chemistry at Milan University. With an experience of more than 30 years in the pharmaceutical industry, Giancarlo has joined Eudax in 2007 from Cephalon Europe (Global Director Haematology). Since 2001 as V.P. Business Development at Novuspharma, an oncology focused R&D biotech company, and later at Cell Therapeutics Europe (following the merger with CTI Inc). He previously built his experience at big pharma, as Global Licensing Director Oncology at Boehringer Mannheim and Head of NSAID/Osteoporosis Therap.Area at Roche, (including Aulin®, the second top selling drug in Italy) and mid-size international companies such as Recordati (Export), Poli (Licensing), and Societa’ Prodotti Antibiotici (Licensing, Acquisitions), operating on international markets in Europe, North America and Far East (esp. Japan).
DML at I.U.L.M. University of Milan, English and German Teaching, Interpreter and Translator Degree at Scuola Superiore per Interpreti e Traduttori of Florence. Since October 2009 Director of General Affairs (Human Resources, Purchasing, office procedures). Since 2007 at Eudax as clinical project manager (Clinical Trials Applications). Since 1998 at the Ethics Committee of Fondazione I.R.C.C.S. Policlinico San Matteo – Pavia, interacting with both sponsors and clinical investigators in the management of Clinical Trials Applications, managing all necessary Regulatory Activities according to European and national legislation on GCP. Previous apprenticeship at SGZ Bank AG- Karlsruhe - Germany, accruing experience in financial and legal translation; language counselling to the Criminal Court of Pavia.
Master Degree in Biomedical Engineering at University of Genoa, Faculty of Engineering, Italy. He is active member of several national and international technical and scientific societies: Medical Device Technical Commission U4220 of UNI (Italian Organization for Standardization), SSFA (Society for Applied Pharmacological Sciences), RAPS (Regulatory Affairs Professional Society). Before joining Eudax as Director of Medical Device Technology in 2010, Enrico covered the position of Executive Manager, Regulatory and Quality Assurance for Meditrial s.r.l; as Technical Director of Anthen Ltd.; as Product Manager at Piezosurgery s.r.l.
Degree in Medicine, specialization in Nuclear Medicine at Pisa University, specialization in Clinical Pharmacology at Pavia University.
More than 20 years experience in Pharmaceuticals (Ciba Geigy, Roche, Gilead , Biogen Dompe') with broad experience in clinical operations and medical affairs across different therapeutical areas, Pier Luigi has joined Eudax beginning 2011 coming from Biogen Dompe' Italy where he covered the position of Medical Director spending his activity in the field of Neurology, in particular MS. He previously was Director of Medical Affairs at Gilead Sciences Italy contributing to the launch of several products in HIV (Viread, Truvada, Atripla) as well as hepatitis (Hepsera, Viread).
He also spent ten years at Roche Italy as medical responsible of HIV, hepatitis, transplantation and antibiotics, supporting the launch of Hivid , Invirase, Viracept, Fortovase and CellCept.